Apyx Medical (APYX) Change in Receivables (2011 - 2026)

Apyx Medical has reported Change in Receivables for 16 years, with the latest figure at -$4.0 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Receivables changed 0.25% year-over-year to -$4.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (up 404.9% YoY), and the FY2025 full-year result was $1.3 million, down 35.23% from the prior year.
• Change in Receivables for Q1 2026 stood at -$4.0 million, down from $3.9 million in the prior quarter.
• The five-year high for Change in Receivables was $3.9 million in Q4 2025, with the low at -$4.0 million in Q1 2026.
• Historically, Change in Receivables has averaged $62176.5 across 5 years, with a median of $291000.0 in 2024.
• The largest YoY upside for Change in Receivables was 496.1% in 2025 against a maximum downside of 261.86% in 2025.
• Apyx Medical's Change in Receivables stood at $1.4 million in 2022, then increased by 1.99% to $1.4 million in 2023, then soared by 110.85% to $2.9 million in 2024, then jumped by 33.67% to $3.9 million in 2025, then slumped by 201.46% to -$4.0 million in 2026.
• The last three Change in Receivables figures came in at -$4.0 million (Q1 2026), $3.9 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.